MediciNova Inc. (MNOV)
MediciNova Statistics
Share Statistics
MediciNova has 49.05M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 10.67% |
| Shares Floating | 46.48M |
| Failed to Deliver (FTD) Shares | 3.13K |
| FTD / Avg. Volume | 16.59% |
Short Selling Information
The latest short interest is 182.2K, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 182.2K |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.39% |
| Short Ratio (days to cover) | 11.2 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -3.96. MediciNova's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -3.96 |
| PS Ratio | 0 |
| Forward PS | 87.6 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MediciNova.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.88, with a Debt / Equity ratio of 0.
| Current Ratio | 13.88 |
| Quick Ratio | 13.88 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $76.92K |
| Profits Per Employee | $-659.35K |
| Employee Count | 13 |
| Asset Turnover | null |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3.05K |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -11.84% in the last 52 weeks. The beta is 0.75, so MediciNova's price volatility has been higher than the market average.
| Beta | 0.75 |
| 52-Week Price Change | -11.84% |
| 50-Day Moving Average | 1.64 |
| 200-Day Moving Average | 1.71 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (20 Days) | 18.86K |
Income Statement
In the last 12 months, MediciNova had revenue of 1M and earned -8.57M in profits. Earnings per share was -0.17.
| Revenue | 1M |
| Gross Profit | 1M |
| Operating Income | -9.9M |
| Net Income | -8.57M |
| EBITDA | -9.88M |
| EBIT | -9.9M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 40.36M in cash and 193.77K in debt, giving a net cash position of 40.17M.
| Cash & Cash Equivalents | 40.36M |
| Total Debt | 193.77K |
| Net Cash | 40.17M |
| Retained Earnings | -426.75M |
| Total Assets | 55.88M |
| Working Capital | 38.12M |
Cash Flow
In the last 12 months, operating cash flow was -10.64M and capital expenditures -895, giving a free cash flow of -10.64M.
| Operating Cash Flow | -10.64M |
| Capital Expenditures | -895 |
| Free Cash Flow | -10.64M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | -990.03% |
| FCF Margin | -1064.39% |
Dividends & Yields
MNOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MNOV is $9, which is 571.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 571.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 0.37 |
| Piotroski F-Score | 3 |